Get started
Author

Deborah Fontaine

The Parkinson Progression Marker Initiative (PPMI)
2011 · Kenneth Marek, Danna Jennings, et al. · Progress in Neurobiology · 1,902
Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial
2000 · Robert G. Holloway, Ira Shoulson, et al. · JAMA · 800
A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
2014 · The Parkinson Study Group QE3 Investigators, M. Flint Beal, et al. · JAMA Neurology · 410
PDF
Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease
2004 · Clifford W. Shults, M. Flint Beal, et al. · Experimental Neurology · 222
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
2017 · Brit Mollenhauer, Chelsea J. Caspell-Garcia, et al. · Neurology · 153
PDF
Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q 10 in parkinsonian patients
1998 · C. W. Shults, M. Flint Beal, et al. · Neurology · 116
α-Synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy
2006 · Clifford W. Shults, Jennifer M. Barrett, et al. · Neuroscience Letters · 15
Works count: 8
Citation count: 3,770
H-index: 8
I10-index: 8
Year
Topic
Type